Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety, tolerability, pharmacokinetics, and itraconazole interaction study of RO7268489 in healthy participants
NL-OMON59230Phase 1Completed
- Sponsor
- Roche
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of RO7268489 (2 arms), sponsored by Roche. Started May 2024; status: completed.
02
Drugs
RO7268489
Beyond the preview
Go deeper on NL-OMON59230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59230.